Recombinant Pig IL-6 Protein (HEK293), N-His

Interleukin-6 (IL-6) is a multifunctional cytokine that plays a critical role in immune response, inflammation, and hematopoiesis. It is produced by various cell types, including T cells, macrophages, and fibroblasts, and its dysregulation is associated with numerous pathological conditions, such as autoimmune diseases, cancers, and chronic inflammatory disorders. Research into IL-6 has gained prominence due to its dual role as both a pro-inflammatory and anti-inflammatory mediator, which complicates its therapeutic targeting. Recombinant IL-6 proteins are essential tools for studying its biological effects and mechanisms of action. These proteins can be produced using recombinant DNA technology, allowing for the generation of large quantities of biologically active IL-6 for research purposes. Investigations involving IL-6 recombinant proteins have provided insights into signaling pathways, interactions with IL-6 receptors, and the cytokine’s role in disease processes. Furthermore, IL-6 has emerged as a potential therapeutic target, prompting the development of IL-6 inhibitors for treating various diseases, including rheumatoid arthritis and COVID-19. Understanding the structure-function relationship of IL-6 through recombinant protein studies is crucial for the design of effective interventions, making the research into IL-6 recombinant proteins a significant area in cellular and molecular biology, as well as in clinical applications.